The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 818.20
Bid: 817.40
Ask: 818.80
Change: 34.00 (4.34%)
Spread: 1.40 (0.171%)
Open: 783.80
High: 819.80
Low: 772.60
Prev. Close: 784.20
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on HMRC Investigation

10 Aug 2023 07:01

RNS Number : 8629I
Entain PLC
10 August 2023
 

10 August 2023

Entain plc

("Company" and, together with its subsidiaries, "Group")

Update on HMRC Investigation

 

Entain plc (LSE: ENT), the leading global sports betting, gaming, and interactive entertainment group, announces that it has taken a £585 million provision in respect of its ongoing deferred prosecution agreement (DPA) negotiations with the Crown Prosecution Service (CPS).

The Company previously announced an investigation by HMRC into its legacy Turkish facing business, which it sold in 2017, and subsequently announced that it is in DPA negotiations with the CPS to resolve the ongoing HMRC investigation.

The DPA negotiations have now progressed to the point where the Company believes that it is likely to be able to agree a resolution of the HMRC investigation insofar as it relates to the Company and the Group. While the full terms of a DPA are subject to judicial approval, the Company has a sufficient degree of confidence to take a provision of £585 million against a potential settlement, which would be paid over a four-year period in relation to alleged offences under Section 7 of the Bribery Act 2010. The Company currently anticipates judicial approval will be sought during Q4 2023.

Section 7 of the Bribery Act 2010 relates to the failure of a relevant commercial organisation to have adequate procedures in place designed to prevent persons associated with it from undertaking bribery for the benefit of the commercial organisation.

The amount of the provision has been calculated on the basis that the Company will receive full credit for its extensive co-operation with the investigation prior, and subsequent, to entering into any DPA.

Since the investigation first commenced, the Group has undertaken a comprehensive review of anti-bribery policies and procedures and has taken decisive action to significantly strengthen its wider compliance programme and related controls.

The Board looks forward to pursuing an orderly conclusion to this matter and drawing a line under these legacy issues involving former third-party suppliers and former employees of the Group. The Group is now licensed in more than 40 territories and, as previously disclosed, is committed to operating only in markets that are regulated or where it sees a clear path to domestic regulation.

Barry Gibson, Chairman stated "We are pleased to be making good progress towards drawing a line under this historical issue, which relates to a business that was sold by a former management team of the Group nearly six years ago. We have been working closely with the CPS throughout this process, and they have recognised our extensive co-operation. Following a complete overhaul of our business model, strategy and culture in the last few years, the Entain of today bears no resemblance to the GVC of yesterday."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of English law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for releasing this announcement on behalf of the Company is Simon Zinger, General Counsel. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Forward-looking statements

This document contains certain statements that are forward-looking statements. They appear in a number of places throughout this document and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees. These forward-looking statements include all matters that are not historical facts. By their nature, these statements involve risks and uncertainties since future events and circumstances can cause results and developments to differ materially from those anticipated. Any such forward-looking statements reflect knowledge and information available at the date of preparation of this document. Other than in accordance with its legal or regulatory obligations (including under the Market Abuse Regulation (596/2014) as it forms part of English law by virtue of the European Union (Withdrawal) Act 2018, the Listing Rules, the Disclosure Guidance and Transparency Rules and the Prospectus Rules), the Company undertakes no obligation to update or revise any such forward-looking statements. Nothing in this document should be construed as a profit forecast. The Company and its directors accept no liability to third parties in respect of this document save as would arise under English law.

 

Enquiries:

Company Secretary

 

Investor Relations - Entain plc

 

David Lloyd-Seed, Chief IR & Communications OfficerDavina Hobbs, Head of Investor RelationsAimee Remey, VP US IR

Callum Sims, IR Manager

secretary@entaingroup.com

 

investors@entaingroup.com

 

 

 

Media - Entain plc

 

Lisa Attenborough, Head of Corporate Communications

Jay Dossetter, Head of Corporate PR

Jodie Hitch, PR Manager

 

media@entaingroup.com

 

 

 

Media - Powerscourt

 

Rory Godson / Rob Greening / Russell Lynch

 

Tel: +44 (0) 20 7250 1446

 

entain@powerscourt-group.com

 

About Entain plc

Entain plc (LSE: ENT) is a FTSE100 company and is one of the world's largest sports-betting and gaming groups, operating both online and in the retail sector. The Group owns a comprehensive portfolio of established brands; Sports brands include BetCity, bwin, Coral, Crystalbet, Eurobet, Ladbrokes, Neds, Sportingbet, Sports Interaction and SuperSport; Gaming brands include Foxy Bingo, Gala, GiocoDigitale, Ninja Casino, Optibet, Partypoker and PartyCasino. The Group owns proprietary technology across all its core product verticals and in addition to its B2C operations provides services to a number of third-party customers on a B2B basis.

The Group has a 50/50 joint venture, BetMGM, a leader in sports betting and iGaming in the US. Entain provides the technology and capabilities which power BetMGM as well as exclusive games and products, specially developed at its in-house gaming studios. The Group is tax resident in the UK and is the only global operator to exclusively operate in domestically regulated or regulating markets operating in over 40 territories.

Entain is a leader in ESG, a member of FTSE4Good, the DJSI and is AA rated by MSCI. The Group has set a science-based target, committing to be carbon net zero by 2035 and through the Entain Foundation supports a variety of initiatives, focusing on safer gambling, grassroots sport, diversity in technology and community projects. For more information see the Group's website: www.entaingroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUQURUPWPUB
Date   Source Headline
29th Apr 20247:00 amRNSSuccessful repricing of Term Loans & £600m add-on
26th Apr 20249:56 amRNSBoard Committee Changes
24th Apr 202412:09 pmRNSResult of AGM
17th Apr 20247:00 amRNSQ1 Trading Update
16th Apr 20249:17 amRNSTR1: Notification of Major Holdings
4th Apr 20247:00 amRNSChairman Succession
2nd Apr 20247:00 amRNSBlock Listing Six Monthly Return
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:42 amRNSAnnual Report, AGM and Gender Pay Gap Report
12th Mar 202411:41 amRNSDirector/PDMR Shareholding
12th Mar 202410:00 amRNSBoard Appointment
11th Mar 20241:54 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFY23 results in line with expectations
1st Mar 20247:00 amRNSTotal Voting Rights
19th Feb 20247:00 amRNSTR1: Notification of Major Holdings
8th Feb 20242:00 pmRNSBETMGM FY23 UPDATE
6th Feb 20242:00 pmRNSNotice of BetMGM FY 2023 update
2nd Feb 20244:11 pmRNSNew Board Committee
1st Feb 20247:00 amRNSTotal Voting Rights
3rd Jan 20249:27 amRNSTR1: Notification of Major Holdings
3rd Jan 20247:00 amRNSBoard Appointment
2nd Jan 20248:29 amRNSTotal Voting Rights
15th Dec 20234:00 pmRNSBoard Committee Changes
13th Dec 20237:00 amRNSDirectorate Change
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSBetMGM at Morgan Stanley Consumer Conference
5th Dec 20232:06 pmRNSFinal Approval of Deferred Prosecution Agreement
4th Dec 20232:00 pmRNSBetMGM Business Update
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 202310:42 amRNSStatement regarding KSA decisions
27th Nov 20232:00 pmRNSBetMGM Business Update Event Details
24th Nov 20232:01 pmRNSUpdate on Deferred Prosecution Agreement
15th Nov 202311:00 amRNSDirector/PDMR Shareholding
8th Nov 20232:00 pmRNSTR1: Notification of Major Holdings
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20233:39 pmRNSTR1: Notification of Major Holdings
6th Nov 20239:12 amRNSTR1: Notification of Major Holdings
2nd Nov 20237:00 amRNSQ3 Trading Statement & Business Update
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBoard Appointment
4th Oct 20232:00 pmRNSNotice of BETMGM Business Update Event
4th Oct 202311:30 amRNSTR1: Notification of Major Holdings
2nd Oct 202312:35 pmRNSBlock Listing Six Monthly Return
2nd Oct 20239:11 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSCompletion of acquisition of Angstrom Sports
25th Sep 20237:00 amRNSUpdate on current trading and operational strategy
5th Sep 20232:00 pmRNSBetMGM participate in Bank of America Conference
1st Sep 202310:02 amRNSTotal Voting Rights
21st Aug 20235:15 pmRNSResult of tender offer to shareholders of STS
10th Aug 20237:01 amRNSUpdate on HMRC Investigation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.